BillionToOne, Inc.
BLLN
$97.48+3.04 (+3.21%)
BillionToOne, Inc. is a specialized diagnostics company that innovates by precisely quantifying biological data to create advanced molecular diagnostic solutions.
StreetsValue research for BillionToOne, Inc. (BLLN)
Members get the full report for BillionToOne, Inc.: a fair value estimate and valuation analysis, economic moat rating, growth and profitability factor grades, a bull and bear investment thesis, analyst price targets, insider and congressional trading activity, and which super investors own the stock.